Strategies of diagnosis and treatment for peritoneal metastasis of gastric cancer.
- Author:
Pin LIANG
;
Xiang HU
1
Author Information
1. Department of Gastrointestinal Surgery, The First Affiliated Hospital, Dalian Medical University, Dalian 116011, China. tiandayu_2000@163.com.
- Publication Type:Journal Article
- MeSH:
Antineoplastic Agents;
therapeutic use;
Antineoplastic Protocols;
Combined Modality Therapy;
methods;
Cytoreduction Surgical Procedures;
Early Detection of Cancer;
methods;
Humans;
Hyperthermia, Induced;
Peritoneal Neoplasms;
diagnosis;
secondary;
Prognosis;
Stomach Neoplasms;
mortality;
pathology;
Treatment Outcome
- From:
Chinese Journal of Gastrointestinal Surgery
2017;20(5):500-503
- CountryChina
- Language:Chinese
-
Abstract:
Peritoneal metastasis of gastric cancer is the main cause of death in gastric cancer patients. Peritoneal metastasis of gastric cancer is difficult to diagnose in its early stage due to lack of obvious clinical signs and symptoms, and poor treatment outcomes and prognosis are often associated with late stage peritoneal metastasis. Therefore, it is crucial to utilize effective early diagnostic tools and to improve the long-term outcomes and the prognosis of patients with advanced gastric cancer. Recently, systemic chemotherapy and intraperitoneal chemotherapy are the first line therapy, and cytoreductive operation plus abdominal cavity thermochemotherapy may be the best method in the treatment of peritoneal metastasis. However, conversion therapy has been gradually incorporated into the treatment of peritoneal metastasis of gastric cancer because of the better efficacy and the higher survival.
